|
PANCREATIC CANCER ACTION NETWORK: Posted on Wednesday, April 10, 2013 7:52 PM
PIONEERS OF PROGRESS Pancreatic Cancer Action
Network will fund more than $5 million in research grants this year. Learn about the exciting and innovative projects we
are funding.TO READ MORE CLICK HERE.
SUPPORTING INNOVATION An extraordinary gift from
Tempur-Pedic in memory of Tim Miller and another given in memory of Skip Viragh
will fund our inaugural $1 millionRAN grants. TO READ MORE CLICK HERE.
A SURVIVOR’S STORY When Michael Lippe was
first diagnosed with cancer five years ago, he found the right clinical trial
and treatment to extend his life. |
|
|
ACS: Posted on Wednesday, February 20, 2013 10:33 PM
A lot has happened in the area of cervical cancer this past year. The American Cancer Society, the U.S. Preventive Services Task Force and the American College of Obstetricians and Gynecologists all released virtually identical screening guidelines, leading to less confusion and higher acceptance from health care professionals and the public.
Thanks to screening, cervical cancer is not very common in the U.S., with about 12,340 new cases of invasive cervical cancer expected to be diagnosed in 2013. |
|
|
Memoirs of Cancer/ACS: Posted on Wednesday, February 20, 2013 10:01 PM
When I blogged on Jan 14, 2013 that the mortality rate for cancer had declined, I was elated, but cautious. I was cautious because I was not sure that the mortality rate for African Americans (AA) was equally successful. I was right to be cautious. While there has been improvements in AA death rate numbers, it is not time for total celebration. The American Cancer Society had this to say on this matter:
"The great news is that overall cancer death rates have steadily decreased for African American men and women. |
|
|
NMH: Posted on Monday, February 04, 2013 8:05 PM
Local bands join forces to honor a longtime member of Chicagos music community and raise funds for melanoma research at the Lurie Cancer Center. Thursday, Feb. 7, 2013
Thursday, February 7, 2013 (doors open at 6:30 p.m.)
Lincoln Hall
2424 N. Lincoln Avenue, Chicago
Dan Stock, an active member of Chicago's music community for more than a dozen years, is bringing local bands together to raise money for melanoma research at the Lurie Cancer Center--the same disease that he is battling himself. |
|
|
Robert H. Lurie Comprehensive Cancer Center: Posted on Monday, February 04, 2013 7:51 PM
 Peggy Gilbertsen, RN, is the Lurie Cancer Center's Clinical Trials Recruitment Coordinator, a newly-created position within the Clinical Research Office (CRO). An experienced oncology research nurse with a long history at the Lurie Cancer Center, Peggy is developing a clinical trials education program for patients, caregivers and community members.
What are clinical trials? In cancer care, clinical trials are studies that are designed to answer questions about new ways to prevent, diagnose and treat cancer. |
|
|
Sisters Network Inc.: Posted on Monday, February 04, 2013 7:36 PM
In 2012 Sisters Network hosted its Annual National African American Breast Cancer Conference. The 13th annual conference was held in Houston, Texas, April 12-15. The conference provided an informative platform, designed specifically for AA BC survivors to broaden the scope of knowledge that addresses the breast cancer survivorship crisis affecting African American women across the nation. HOWEVER ..... In preparation for our 20 year anniversary celebration in 2014, Sisters Network® Inc. |
|
|
NCI: Posted on Monday, January 14, 2013 3:20 PM
Over the past several years, the conversation about cancer screening has started to change within the medical community. Be it breast, prostate, or ovarian cancer, the trend is to recommend less routine screening, not more. These recommendations are based on an emerging—if counterintuitive—understanding that more screening does not necessarily translate into fewer cancer deaths and that some screening may actually do more harm than good.Much of the confusion surrounding the benefits of screening comes from interpreting the statistics that are often used to describe the results of screening studies. |
|
|
NCI: Posted on Monday, January 14, 2013 3:16 PM
According to the latest national data, overall death rates from cancer declined from 2000 through 2009 in the United States, maintaining a trend seen since the early 1990s. Mortality fell for most cancer types, including the four most common types of cancer in the United States (lung, colon and rectum,breast, and prostate), although the trend varied by cancer type and across racial and ethnic groups.
The complete "Annual Report to the Nation on the Status of Cancer, 1975–2009" appeared January 7 in the |
|
|
Posted on Friday, December 07, 2012 10:31 PM
Celgene Corporation (Celgene) conducted a phase III clinical trial with the intent to show that the combination of its chemotherapy drug, ABRAXANE®, with gemcitabine would improve overall survival in patients with untreated, metastatic pancreatic adenocarcinoma when compared with gemcitabine alone. Use of gemcitabine alone has been the standard of care for pancreatic cancer.
In the study, ABRAXANE in combination with gemcitabine demonstrated a statistically significant improvement in overall survival compared to gemcitabine alone. |
|
|
Memoirs of Cancer Book: Posted on Wednesday, December 05, 2012 11:05 PM
https://www.facebook.com/video/video.php?v=10150635846921971
If you can't open this video go to the link above.
Cancer is finally cured in Canada but Big Pharma has no interest.Cancer is finally cured in Canada but Big Pharma has no interest. The fact that the international drug & medical industry have no interest is because the cure is really cheaper than a chocolate bar and it won't get them to gain any profits at all. Besides, if people had the cure so easily, how will these medical companies make money out of that? |
|
